| 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data‐driven methodology … CH Shiboski, SC Shiboski, R Seror, LA Criswell, M Labetoulle, ... Arthritis & rheumatology 69 (1), 35-45, 2017 | 2329 | 2017 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1743* | 2021 |
| EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome R Seror, P Ravaud, SJ Bowman, G Baron, A Tzioufas, E Theander, ... Annals of the rheumatic diseases 69 (6), 1103-1109, 2010 | 976 | 2010 |
| Sjögren syndrome P Brito-Zerón, C Baldini, H Bootsma, SJ Bowman, R Jonsson, X Mariette, ... Nature reviews Disease primers 2 (1), 1-20, 2016 | 741 | 2016 |
| Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome CJ Lessard, H Li, I Adrianto, JA Ice, A Rasmussen, KM Grundahl, JA Kelly, ... Nature genetics 45 (11), 1284-1292, 2013 | 553 | 2013 |
| EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome R Seror, P Ravaud, X Mariette, H Bootsma, E Theander, A Hansen, ... Annals of the rheumatic diseases 70 (6), 968-972, 2011 | 504 | 2011 |
| Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study S Dass, SJ Bowman, EM Vital, K Ikeda, CT Pease, J Hamburger, ... Annals of the rheumatic diseases 67 (11), 1541-1544, 2008 | 456 | 2008 |
| EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies M Ramos-Casals, P Brito-Zerón, S Bombardieri, H Bootsma, S De Vita, ... Annals of the rheumatic diseases 79 (1), 3-18, 2020 | 449 | 2020 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 440* | 2021 |
| Ectopic expression of the B cell–attracting chemokine BCA‐1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center–like … N Amft, SJ Curnow, D Scheel‐Toellner, A Devadas, J Oates, J Crocker, ... Arthritis & Rheumatism 44 (11), 2633-2641, 2001 | 350 | 2001 |
| EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide R Seror, SJ Bowman, P Brito-Zeron, E Theander, H Bootsma, A Tzioufas, ... RMD open 1 (1), e000022, 2015 | 325 | 2015 |
| Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10274), 605, 2021 | 317 | 2021 |
| Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient … R Seror, H Bootsma, A Saraux, SJ Bowman, E Theander, JG Brun, ... Annals of the rheumatic diseases 75 (2), 382-389, 2016 | 316 | 2016 |
| Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements M Ramos-Casals, P Brito-Zerón, R Seror, H Bootsma, SJ Bowman, ... Rheumatology 54 (12), 2230-2238, 2015 | 307 | 2015 |
| Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI) R Seror, E Theander, JG Brun, M Ramos-Casals, V Valim, T Dörner, ... Annals of the rheumatic diseases 74 (5), 859-866, 2015 | 303 | 2015 |
| Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK SJ Bowman, GH Ibrahim, G Holmes, J Hamburger, JR Ainsworth Scandinavian journal of rheumatology 33 (1), 39-43, 2004 | 285 | 2004 |
| Utility of ultrasound joint counts in the prediction of rheumatoid arthritis in patients with very early synovitis A Filer, P De Pablo, G Allen, P Nightingale, A Jordan, P Jobanputra, ... Annals of the rheumatic diseases 70 (3), 500-507, 2011 | 273 | 2011 |
| Randomized controlled trial of rituximab and cost‐effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome SJ Bowman, CC Everett, JL O'Dwyer, P Emery, C Pitzalis, WF Ng, ... Arthritis & Rheumatology 69 (7), 1440-1450, 2017 | 272 | 2017 |
| Elective cancer surgery in COVID-19–free surgical pathways during the SARS-CoV-2 pandemic: an international, multicenter, comparative cohort study JC Glasbey, D Nepogodiev, JFF Simoes, O Omar, E Li, ML Venn, PGDME, ... Journal of Clinical Oncology 39 (1), 66-78, 2021 | 262 | 2021 |
| Primary Sjögren's Syndrome: health experiences and predictors of health quality among patients in the United States B Segal, SJ Bowman, PC Fox, FB Vivino, N Murukutla, J Brodscholl, ... Health and quality of life outcomes 7, 1-9, 2009 | 262 | 2009 |
